Magnesium Glycinate vs Citrate vs Threonate: Which Form Should You Take?

2026-10-24 · Author: Vigilant Crow

Our picks

Key takeaways

  • Elemental dose and whether you were low to begin with still matter most, but the form is not irrelevant: citrate is more likely to loosen stools, glycinate is usually gentler, and L-threonate is the form with targeted (still limited, often industry-funded) brain and sleep trials. There is no strong head-to-head sleep trial proving one form beats another at the same elemental dose.
  • Citrate absorbs well and has a laxative effect; glycinate is gentler on the stomach; L-threonate is pricey and has thinner, industry-funded human evidence.
  • Sleep evidence for magnesium is real but modest, including both older-adult trials and more recent studies in younger adults.
  • The upper limit for supplemental magnesium is 350 mg per day for adults unless a doctor advises more.

Magnesium is one of the most popular supplements for sleep and stress, and the shelf is confusing: glycinate, citrate, threonate, oxide, malate, "bisglycinate chelate." Here is what the research actually supports, and how to pick a form without overpaying.

First, how much magnesium do you need?

The U.S. recommended intake is about 400 to 420 mg a day for adult men and 310 to 320 mg for adult women, from food and supplements combined. The tolerable upper limit for supplemental magnesium is 350 mg a day for adults. Going over it mainly causes diarrhea, but in people with poor kidney function magnesium can build up to dangerous levels (NIH Office of Dietary Supplements).

Many people fall short through diet alone, which is the main reason supplementing can help. If you already eat plenty of leafy greens, nuts, seeds, beans and whole grains, the benefit will likely be smaller.

Read the label for "elemental" magnesium. "Magnesium glycinate 1,000 mg" is not 1,000 mg of magnesium. Only a fraction of the compound's weight is the mineral itself, so always look for the elemental amount on the Supplement Facts panel.

The three forms compared

Glycinate (bisglycinate) Citrate L-threonate
Elemental Mg by weight ~14% ~16% ~7-8%
Absorption Good Good (better than oxide in trials) Good; marketed for brain uptake
Stomach / bowel effects Gentlest Can loosen stools (used as a laxative at high doses) Generally gentle
Typical cost per 100 mg elemental Moderate Lowest Highest
Best human evidence General magnesium research Absorption studies One small cognition trial plus one 2025 sleep and cognition trial, both industry-funded
Good fit for Evening use, sensitive stomach Budget, or if you tend toward constipation People who want to try it for focus and can afford it
Example product Thorne Magnesium Bisglycinate; Pure Encapsulations Magnesium (glycinate) Pure Encapsulations Magnesium Citrate Jarrow MagMind (Magtein)

Magnesium citrate

A randomized, double-blind study comparing magnesium preparations found citrate was more bioavailable than oxide (Walker et al., 2003). It is inexpensive and well absorbed. The catch is that citrate draws water into the gut, so higher doses can loosen stools.

Pros: cheap, well absorbed, widely available. Cons: possible digestive upset; less pleasant if you are sensitive.

Magnesium glycinate (bisglycinate)

Magnesium bound to the amino acid glycine. It is the form most people pick for evening use because it rarely causes digestive problems. You will see claims that glycine itself improves sleep, but the amount of glycine in a typical magnesium dose is small, so do not count on that as a separate benefit.

Pros: gentle on the stomach, good absorption, easy to take at night. Cons: costs more than citrate; bulky capsules because of the low magnesium percentage.

Magnesium L-threonate (Magtein)

This form got famous because a 2010 study in rats showed it raised brain magnesium and improved learning and memory (Slutsky et al., 2010). Rat results do not automatically carry over to people.

Human data is limited. A 2016 trial in older adults with cognitive complaints reported improvements (Liu et al., 2016), and a 2025 randomized trial in 100 adults with poor sleep found improvements in some cognition scores, reaction time and self-reported sleep impairment over 6 weeks, but no difference in sleep measured by a wearable (Lopresti & Smith, 2025). Both studies were funded or run by companies connected to the product, which does not make them wrong, but it is a reason for caution.

Pros: the only form with targeted brain research; gentle. Cons: expensive, low elemental magnesium per capsule (you often need 3 or more capsules), and thin, industry-linked evidence.

What about sleep and stress?

The honest summary: magnesium is a reasonable, low-cost thing to try, especially if your diet is low in it. It is not a sleeping pill.

Why brand and testing matter

Supplements are not approved by the FDA before sale, so quality varies. Thorne, Pure Encapsulations and Jarrow are established brands with published quality programs. For extra assurance, look for an NSF or USP seal and confirm it on the certifier's website.

How to choose

Who this is not for

Bottom line

Start with glycinate for evenings or citrate for value, keep supplemental magnesium at or under 350 mg a day unless a doctor says otherwise, and treat threonate as an interesting but unproven upgrade.

Sources

  1. NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. ods.od.nih.gov
  2. Walker AF, et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003. PubMed 14596323
    In plain English: Randomized, double-blind, placebo-controlled trial in 46 healthy adults taking 300 mg/day elemental magnesium for 60 days as amino-acid chelate, citrate or oxide. Citrate raised blood/urine/saliva magnesium markers the most; oxide was no different from placebo. Limits: small; measured absorption markers, not health outcomes.
  3. Slutsky I, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010. PubMed 20152124 · doi:10.1016/j.neuron.2009.12.026
    In plain English: Animal study in rats. A new compound, magnesium L-threonate, raised brain magnesium and improved learning and memory tests. Limits: rats, not people; funded in part by researchers linked to the compound.
  4. Liu G, et al. Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults. J Alzheimers Dis. 2016. PubMed 26519439 · doi:10.3233/JAD-150538
    In plain English: Randomized, double-blind, placebo-controlled trial of 44 adults aged 50–70 with memory complaints taking MMFS-01 (magnesium L-threonate) for 12 weeks. Improved overall cognitive scores vs placebo; sleep and anxiety effects could not be judged due to placebo effect. Limits: small; funded by the company that makes it.
  5. Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein) on cognitive performance and sleep quality in adults. Front Nutr. 2025. PubMed 41601871 · doi:10.3389/fnut.2025.1729164
    In plain English: Randomized, double-blind, placebo-controlled trial of 100 adults aged 18–45 with poor sleep taking 2 g/day Magtein (magnesium L-threonate) for 6 weeks. Improved several cognition scores and some self-reported, but not device-measured, sleep measures. Limits: 6 weeks; product-maker involvement should be checked.
  6. Abbasi B, et al. The effect of magnesium supplementation on primary insomnia in elderly. J Res Med Sci. 2012. PubMed 23853635
    In plain English: Randomized, double-blind, placebo-controlled trial in 46 older adults with insomnia in Iran, 500 mg elemental magnesium as oxide daily for 8 weeks. Improved insomnia questionnaire scores and some sleep measures; total sleep time did not change. Limits: small, older adults, mostly self-reported sleep.
  7. Schuster J, et al. Magnesium bisglycinate supplementation in healthy adults reporting poor sleep: a randomized, placebo-controlled trial. Nat Sci Sleep. 2025. PMC12412596 · PubMed 40918053 · doi:10.2147/NSS.S524348
    In plain English: Randomized, double-blind, placebo-controlled trial of 155 adults aged 18–65 reporting poor sleep, taking 250 mg/day elemental magnesium as bisglycinate for 4 weeks. Modestly improved insomnia scores vs placebo, with a larger effect in people with lower dietary magnesium. Limits: 4 weeks; self-reported sleep; small effect size.
  8. Nielsen FH, et al. Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res. 2010. PubMed 21199787 · doi:10.1684/mrh.2010.0220
    In plain English: Randomized trial of 100 adults older than 51 with poor sleep, 320 mg/day magnesium as citrate vs sodium-citrate placebo for 7 weeks. Sleep scores improved in both the magnesium and placebo groups, so the study did not show a magnesium-specific sleep benefit. Limits: older adults; sleep improved regardless of assignment.
  9. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis. BMC Complement Med Ther. 2021. PubMed 33865376 · doi:10.1186/s12906-021-03297-z
    In plain English: Systematic review and meta-analysis of 3 randomized trials (151 older adults) on oral magnesium for insomnia. Magnesium shortened time to fall asleep by about 17 minutes vs placebo, but evidence quality was low to very low. Limits: few, small trials.
  10. Arab A, et al. The role of magnesium in sleep health: a systematic review of available literature. Biol Trace Elem Res. 2023. PubMed 35184264 · doi:10.1007/s12011-022-03162-1
    In plain English: Systematic review of 9 studies (observational and trials) on magnesium and sleep. Observational studies linked higher magnesium to better sleep, but trials showed an uncertain effect. Limits: mostly observational; few good trials.
  11. Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress: a systematic review. Nutrients. 2017. PubMed 28445426 · doi:10.3390/nu9050429
    In plain English: Systematic review of 18 studies on magnesium and anxiety/stress. Some suggestion magnesium helps self-reported anxiety in anxiety-prone people, but the overall evidence quality was poor. Limits: weak, varied studies.